Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer

Yuyang Xia,Tianjiao Pei,Junjie Zhao,Zilin Wang,Yu Shen,Yang Yang,Jiayu Liang

DOI: https://doi.org/10.1038/s41420-024-01832-8

2024-02-15

Cell Death Discovery

Abstract:Long noncoding RNAs (lncRNAs) are a group of noncoding RNAs with transcript lengths of >200 nucleotides. Mounting evidence suggests that lncRNAs are closely associated with tumorigenesis. LncRNA H19 (H19) was the first lncRNA to function as an oncogene in many malignant tumors. Apart from the established role of H19 in promoting cell growth, proliferation, invasion, migration, epithelial-mesenchymal transition (EMT), and metastasis, it has been recently discovered that H19 also inhibits programmed cell death (PCD) of cancer cells. In this review, we summarize the mechanisms by which H19 regulates PCD in cancer cells through various signaling pathways, molecular mechanisms, and epigenetic modifications. H19 regulates PCD through the Wnt/β-catenin pathway and the PI3K–Akt–mTOR pathway. It also acts as a competitive endogenous RNA (ceRNA) in PCD regulation. The interaction between H19 and RNA-binding proteins (RBP) regulates apoptosis in cancer. Moreover, epigenetic modifications, including DNA and RNA methylation and histone modifications, are also involved in H19-associated PCD regulation. In conclusion, we summarize the role of H19 signaling via PCD in cancer chemoresistance, highlighting the promising research significance of H19 as a therapeutic target. We hope that our study will contribute to a broader understanding of H19 in cancer development and treatment.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the functions and mechanisms of long non - coding RNA H19 in programmed cell death (PCD) of cancer cells. Specifically, the paper focuses on how H19 regulates the programmed death of cancer cells through different signaling pathways, molecular mechanisms and epigenetic modifications, especially processes such as apoptosis, autophagy, and necroptosis. The paper also discusses the role of H19 as a competing endogenous RNA (ceRNA) and the way it interacts with microRNA (miRNA), and these interactions are of great significance for cancer development and treatment.

The main contribution of the paper lies in systematically summarizing the multiple mechanisms of H19 in regulating the programmed death of cancer cells. This not only helps to deeply understand the role of H19 in the occurrence and development of cancer, but also provides a theoretical basis for the development of new cancer diagnosis and treatment methods. For example, by regulating H19 - related signaling pathways, it may be helpful to overcome cancer chemotherapy resistance and improve the treatment effect.